Evidence map›Paper›PMID 33072016›Full record

ArticleFrontiers in microbiology2020

A Novel Peptide Antibiotic Produced by

Alexey S Vasilchenko, William T Julian, Olda A Lapchinskaya, Genrikh S Katrukha, Vera S Sadykova, Eugene A Rogozhin

Abstract read
In one paragraph

Article in Frontiers in microbiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Gausemycin A-ResistantMicroorganisms · 2023
    Article
  6. Article
  7. Article
  8. Recently Discovered Secondary Metabolites fromMolecules (Basel, Switzerland) · 2022
    Review
  9. Frontiers in microbiology · 2022
    Article
  10. Frontiers in microbiology · 2022
    Review
  11. International journal of molecular sciences · 2021
    Review
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Alexey S VasilchenkoLaboratory of Antimicrobial Resistance, Institute of Environmental and Agricultural Biology (X-BIO), Tyumen State University, Tyumen, Russia.
William T JulianLaboratory of Antimicrobial Resistance, Institute of Environmental and Agricultural Biology (X-BIO), Tyumen State University, Tyumen, Russia.
Olda A LapchinskayaGause Institute of New Antibiotics, Moscow, Russia.
Genrikh S KatrukhaGause Institute of New Antibiotics, Moscow, Russia.
Vera S SadykovaGause Institute of New Antibiotics, Moscow, Russia.
Eugene A RogozhinGause Institute of New Antibiotics, Moscow, Russia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this work, we report the isolation and detailed functional characterization for the new non-ribosomally synthesized antibiotic 5812-A/C, which was derived from metabolites of

Indexed as

anti-biofilm actioncalcium-depending antibioticdaptomycinlipoglycopeptide antibioticpeptide antibioticStreptomyces roseoflavus

Identifiers

PMID33072016
PMCPMC7533577

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.